This inventor holds 3 USPTO granted patents. Top assignees: Bristol-Myers Squibb Pharma Company, Dupont Pharmaceuticals Company, Dupont Pharmaceuticals, Inc.. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2000-2002
Title: Jeffrey W Corbett: Innovator in HIV Research
Introduction
Jeffrey W Corbett is a notable inventor based in Haddon Heights, NJ (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of HIV treatments. With a total of 3 patents to his name, Corbett's work has had a meaningful impact on medical science.
Latest Patents
Corbett's latest patents include innovative compounds such as 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones, which are useful as HIV reverse transcriptase inhibitors. Another significant patent involves 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinthiones, which are also aimed at combating HIV. These inventions relate to compounds that can serve as inhibitors of HIV reverse transcriptase, along with pharmaceutical compositions and diagnostic kits for treating viral infections.
Career Highlights
Throughout his career, Jeffrey W Corbett has worked with prominent organizations, including DuPont Pharmaceuticals, Inc. and DuPont Pharmaceuticals Company. His experience in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
Corbett has collaborated with various professionals in his field, including his coworker Soo Sung Ko. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jeffrey W Corbett is a distinguished inventor whose work in HIV research has led to valuable patents and advancements in treatment options. His contributions continue to influence the pharmaceutical industry and improve the lives of those affected by viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile